• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国/墨西哥边境地区局限型 ALL 患者队列的基因组图谱。

The Genomic Landscape of a Restricted ALL Cohort from Patients Residing on the U.S./Mexico Border.

机构信息

Department of Biological Sciences, College of Science, The University of Texas at El Paso, El Paso, TX 79968, USA.

Department of Mathematical Sciences, College of Science, The University of Texas at El Paso, El Paso, TX 79968, USA.

出版信息

Int J Environ Res Public Health. 2021 Jul 9;18(14):7345. doi: 10.3390/ijerph18147345.

DOI:10.3390/ijerph18147345
PMID:34299796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8307122/
Abstract

Next-generation sequencing (NGS) has identified unique biomarkers yielding new strategies in precision medicine for the treatment of Acute lymphoblastic leukemia (ALL). Hispanics show marked health disparities in ALL, often absent in clinical trials or cancer research. Thus, it is unknown whether Hispanics would benefit equally from curated data currently guiding precision oncology. Using whole-exome sequencing, nine ALL patients were screened for mutations within genes known to possess diagnostic, prognostic and therapeutic value. Genes mutated in Hispanic ALL patients from the borderland were mined for potentially pathogenic variants within clinically relevant genes. G12A was detected in this unique cohort and its frequency in Hispanics from the TARGET-ALL Phase II database was three-fold greater than that of non-Hispanics. N642H was also detected with low frequency in Hispanic and non-Hispanic individuals within TARGET. Its detection within this small cohort may reflect a common event in this demographic. Such variants occurring in the MAPK and JAK/STAT pathways may be contributing to Hispanic health disparities in ALL. Notable variants in , , and were observed in the ALL borderland cohort, with C19W occurring most frequently. Further investigations on the pathogenicity of these variants are needed to assess their relevance in ALL.

摘要

下一代测序(NGS)已经确定了独特的生物标志物,为急性淋巴细胞白血病(ALL)的精准医学治疗提供了新策略。西班牙裔人群在 ALL 方面存在明显的健康差异,而这些差异通常在临床试验或癌症研究中没有得到体现。因此,目前尚不清楚西班牙裔人群是否能从当前指导精准肿瘤学的精选数据中平等受益。本研究通过全外显子测序,筛选了 9 名 ALL 患者的基因中的突变,这些基因在具有诊断、预后和治疗价值方面具有已知的作用。在边境地区的西班牙裔 ALL 患者中,挖掘了临床相关基因中潜在致病性变异的基因。在这个独特的队列中检测到 G12A,其在 TARGET-ALL 二期数据库中西班牙裔患者中的频率是非西班牙裔患者的三倍。在 TARGET 中也检测到了低频率的 N642H,但在西班牙裔和非西班牙裔个体中。在这个小队列中检测到它可能反映了该人群中的一个常见事件。发生在 MAPK 和 JAK/STAT 通路中的此类变异可能是导致 ALL 中西班牙裔健康差异的原因。在 ALL 边境队列中观察到 、 和 中的显著变异,其中 C19W 最常见。需要进一步研究这些变异的致病性,以评估它们在 ALL 中的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb4/8307122/c06fe4706730/ijerph-18-07345-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb4/8307122/0cbd8578dc1b/ijerph-18-07345-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb4/8307122/d0e6fd968d60/ijerph-18-07345-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb4/8307122/9af7ad2f0cbc/ijerph-18-07345-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb4/8307122/c06fe4706730/ijerph-18-07345-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb4/8307122/0cbd8578dc1b/ijerph-18-07345-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb4/8307122/d0e6fd968d60/ijerph-18-07345-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb4/8307122/9af7ad2f0cbc/ijerph-18-07345-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb4/8307122/c06fe4706730/ijerph-18-07345-g004.jpg

相似文献

1
The Genomic Landscape of a Restricted ALL Cohort from Patients Residing on the U.S./Mexico Border.美国/墨西哥边境地区局限型 ALL 患者队列的基因组图谱。
Int J Environ Res Public Health. 2021 Jul 9;18(14):7345. doi: 10.3390/ijerph18147345.
2
The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.基于个体基因组数据,使用泛药物优先考虑 T-ALL 患者的抗癌药物治疗。
BMC Cancer. 2019 Oct 26;19(1):1005. doi: 10.1186/s12885-019-6209-9.
3
Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.复发性儿童高超二倍体急性淋巴细胞白血病的下一代测序揭示了通常与高危患者相关的突变。
Leuk Res. 2015 Sep;39(9):990-1001. doi: 10.1016/j.leukres.2015.06.005. Epub 2015 Jun 14.
4
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.RNA测序揭示难治性/复发性T细胞急性淋巴细胞白血病的遗传学。预后及治疗意义。
Haematologica. 2016 Aug;101(8):941-50. doi: 10.3324/haematol.2015.139410. Epub 2016 May 5.
5
Resistance Mechanisms to Targeted Therapies in and Non-small Cell Lung Cancer.在 和 非小细胞肺癌中靶向治疗的耐药机制。
Clin Cancer Res. 2018 Jul 15;24(14):3334-3347. doi: 10.1158/1078-0432.CCR-17-2452. Epub 2018 Apr 10.
6
Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non-Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments.前瞻性临床整合基于扩增子的下一代测序方法,以选择晚期非小细胞肺癌患者进行基于基因型的治疗。
Clin Lung Cancer. 2018 Jan;19(1):65-73.e7. doi: 10.1016/j.cllc.2017.06.008. Epub 2017 Jun 23.
7
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.靶向下一代测序在大样本炎性乳腺癌中鉴定出有临床意义的体细胞突变。
Breast Cancer Res. 2018 Aug 7;20(1):88. doi: 10.1186/s13058-018-1007-x.
8
Recurrent chromosomal rearrangements of , and activating JAK/STAT pathway in inflammatory hepatocellular adenomas.炎性肝细胞腺瘤中 、 和 基因的重现性染色体重排激活 JAK/STAT 通路。
Gut. 2020 Sep;69(9):1667-1676. doi: 10.1136/gutjnl-2019-319790. Epub 2020 Jan 6.
9
Quadruple and Truncated MEK3 Mutants Identified from Acute Lymphoblastic Leukemia Promote Degradation and Enhance Proliferation.从急性淋巴细胞白血病中鉴定出的四聚体和截短的 MEK3 突变体促进降解并增强增殖。
Int J Mol Sci. 2021 Nov 11;22(22):12210. doi: 10.3390/ijms222212210.
10
Spectrum of gene mutations identified by targeted next-generation sequencing in Chinese leukemia patients.中国白血病患者通过靶向下一代测序鉴定的基因突变谱。
Mol Genet Genomic Med. 2020 Sep;8(9):e1369. doi: 10.1002/mgg3.1369. Epub 2020 Jul 7.

引用本文的文献

1
JAK1 Pseudokinase V666G Mutant Dominantly Impairs JAK3 Phosphorylation and IL-2 Signaling.JAK1 假激酶 V666G 突变体显性抑制 JAK3 磷酸化和 IL-2 信号通路。
Int J Mol Sci. 2023 Apr 6;24(7):6805. doi: 10.3390/ijms24076805.
2
Quadruple and Truncated MEK3 Mutants Identified from Acute Lymphoblastic Leukemia Promote Degradation and Enhance Proliferation.从急性淋巴细胞白血病中鉴定出的四聚体和截短的 MEK3 突变体促进降解并增强增殖。
Int J Mol Sci. 2021 Nov 11;22(22):12210. doi: 10.3390/ijms222212210.

本文引用的文献

1
Ethnic and border differences on blood cancer presentation and outcomes: A Texas population-based study.基于德克萨斯州人群的研究:血液癌症发病和预后的种族和边境差异。
Cancer. 2021 Apr 1;127(7):1068-1079. doi: 10.1002/cncr.33347. Epub 2020 Dec 3.
2
Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next-generation sequencing technique.基于靶向二代测序技术的急性髓细胞白血病基因突变的特征及其预后意义。
Cancer Med. 2020 Nov;9(22):8457-8467. doi: 10.1002/cam4.3467. Epub 2020 Sep 24.
3
Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia.
儿童高危B细胞急性淋巴细胞白血病的个性化治疗
Ther Adv Hematol. 2020 Jun 2;11:2040620720927575. doi: 10.1177/2040620720927575. eCollection 2020.
4
The My Cancer Genome clinical trial data model and trial curation workflow.《My Cancer Genome 临床试验数据模型与试验管理工作流程》
J Am Med Inform Assoc. 2020 Jul 1;27(7):1057-1066. doi: 10.1093/jamia/ocaa066.
5
Assessing changes in genomic divergence following a century of human-mediated secondary contact among wild and captive-bred ducks.评估在一个世纪的人类介导的野生和圈养鸭之间的二次接触后,基因组分歧的变化。
Mol Ecol. 2020 Feb;29(3):578-595. doi: 10.1111/mec.15343. Epub 2020 Jan 8.
6
Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.治疗诱导的突变驱动复发急性淋巴细胞白血病的基因组景观。
Blood. 2020 Jan 2;135(1):41-55. doi: 10.1182/blood.2019002220.
7
The prognostic significance of Wilms' tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia.Wilms 瘤基因 1(WT1)在 Ph 阴性 B 细胞前体急性淋巴细胞白血病成人患者诊断时表达的预后意义。
Ann Hematol. 2019 Nov;98(11):2551-2559. doi: 10.1007/s00277-019-03789-6. Epub 2019 Sep 6.
8
Low expression of TET2 gene in pediatric acute lymphoblastic leukemia is associated with poor clinical outcome.TET2 基因低表达与儿童急性淋巴细胞白血病不良临床结局相关。
Int J Lab Hematol. 2019 Oct;41(5):702-709. doi: 10.1111/ijlh.13099. Epub 2019 Aug 23.
9
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018.2008年至2018年导致癌症药物获批的临床试验中种族报告与代表性的差异
JAMA Oncol. 2019 Oct 1;5(10):e191870. doi: 10.1001/jamaoncol.2019.1870. Epub 2019 Oct 10.
10
Next-Generation Sequencing in Acute Lymphoblastic Leukemia.急性淋巴细胞白血病中的二代测序。
Int J Mol Sci. 2019 Jun 15;20(12):2929. doi: 10.3390/ijms20122929.